Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Bioactive Small Molecules
  5. 45412

Tocris Bioscience™ SGC 0946
GREENER_CHOICE

Catalog No. 45412
Change view
Click to view available options
Quantity:
2 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
45-412 2 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 45-412 Supplier Tocris Bioscience™ Supplier No. 4541/2
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Highly potent and selective DOT1L inhibitor; cell permeable

SGC 0946 is a highly potent DOT1L methyltransferase inhibitor (Kd = 0.06 nM, IC50 = 0.3 nM in a radioactive assay); blocks H3K79 methylation in A431 cells and MCF10A cells. Inactive at 12 histone methyltransferases and DNMT1. Selectively kills cells transformed with the MLL-AF9 fusion oncogene in an in vitro model of leukemia; lowers levels of MLL target genes HOXA9 and Meis1.

To request the negative control for SGC0946, please fill out the SGC0649 request form on the SGC website.

Specifications

Chemical Name or Material 1-[3-[[[(2 R,3 S,4 R,5 R)-5-(4-Amino-5-bromo-7 H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl](isopropyl)amino]propyl]-3-[4-(2,2-dimethylethyl)phenyl]urea
CAS 1561178-17-3
Quantity 2 mg
Target Lysine Methyltransferase Inhibitors
Molecular Formula C28H40BrN7O4
Purity 99%
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.